Drug profile · INN
corifollitropin alfa
ELONVA
corifollitropin alfa (ELONVA) is a follicle stimulating hormone receptor agonist. Associated with Organon Pharma Pty Ltd.
EMA: approved TGA: approved Genito-urinary system and sex hormones (G03) G03GA09
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — corifollitropin alfa
- Class
- Genito-urinary system and sex hormones (G03)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
corifollitropin alfa (ELONVA) is a follicle stimulating hormone receptor agonist. Associated with Organon Pharma Pty Ltd.
Key facts
INN corifollitropin alfa
Brand ELONVA
Mechanism Follicle stimulating hormone receptor agonist
Target Follicle-stimulating hormone receptor
Therapeutic class Genito-urinary system and sex hormones (G03)
ATC code G03GA09
Originator Organon Pharma Pty Ltd
Mechanism of action
Follicle stimulating hormone receptor agonist
Primary target: Follicle-stimulating hormone receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
Related & competitor drugs
Frequently asked questions
What is corifollitropin alfa?
corifollitropin alfa (ELONVA) is a follicle stimulating hormone receptor agonist. Associated with Organon Pharma Pty Ltd.
What is the brand name for corifollitropin alfa?
ELONVA is a marketed brand name for corifollitropin alfa. Check FDA Drugs@FDA for the current US label holder and prescribing information.